Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer

Harriet Wikman; Salla Ruosaari; Penny Nymark; Virinder K. Sarhadi; Juha Saharinen; Esa Vanhala; Antti Karjalainen; Jaakko Hollmén; Sakari Knuutila; Sisko Anttila

Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer

Harriet Wikman
, Salla Ruosaari
, Penny Nymark
, Virinder K. Sarhadi
, Juha Saharinen
, Esa Vanhala
, Antti Karjalainen
, Jaakko Hollmén
, Sakari Knuutila
, Sisko Anttila

Research output: Contribution to journal › Article › Scientific › peer-review

38 Citations (Scopus)

Original language	English
Pages (from-to)	4730-4737
Journal	Oncogene
Volume	26
Issue number	32
Publication status	Published - 2007
MoE publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{57519c91c5784156a8ee217a586dafff,

title = "Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer",

author = "Harriet Wikman and Salla Ruosaari and Penny Nymark and Sarhadi, \{Virinder K.\} and Juha Saharinen and Esa Vanhala and Antti Karjalainen and Jaakko Hollm{\'e}n and Sakari Knuutila and Sisko Anttila",

year = "2007",

language = "English",

volume = "26",

pages = "4730--4737",

journal = "Oncogene",

issn = "1476-5594",

publisher = "Springer",

number = "32",

}

TY - JOUR

T1 - Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer

AU - Wikman, Harriet

AU - Ruosaari, Salla

AU - Nymark, Penny

AU - Sarhadi, Virinder K.

AU - Saharinen, Juha

AU - Vanhala, Esa

AU - Karjalainen, Antti

AU - Hollmén, Jaakko

AU - Knuutila, Sakari

AU - Anttila, Sisko

PY - 2007

Y1 - 2007

M3 - Article

SN - 1476-5594

VL - 26

SP - 4730

EP - 4737

JO - Oncogene

JF - Oncogene

IS - 32

ER -